A retrospective review of the persistence on bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population
Aim: To describe the persistence of biologic disease modifying anti-rheumatic drugs (bDMARDs) in Australian rheumatoid arthritis (RA) patients, and assess the influence of methotrexate and other conventional DMARD (cDMARD) concomitant medications, and treatment line on bDMARD persistence and glucocorticoids usage. Method: RA patients, from the 10% Australian Medicare random sample, aged ≥18 for whom bDMARDs were dispensed were included. Individual sub-cutaneous (SC) anti-tumor necrosis factor-α...[Show more]
|Collections||ANU Research Publications|
|Source:||International Journal of Rheumatic Diseases|
|01_Jones_A_retrospective_review_of_the_2018.pdf||434.67 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.